T790M mutations were not detected in plasma at disease progression for any of the three SCLC‐transformed patients, and two of them (patients 122 and 218) retained the EGFR‐activating mutations in plasma after SCLC transformation. The gene discussed is EGFR; the disease is small cell lung carcinoma.